The purpose of this thread is to collect any worthwhile data on PBT from the threads and sites and this will facilitate perusal by Investors. It also helps to refresh my memory.
Web site: http://www.pranabio.com/
1. Financial: Has about 18 months of cash reserves:
http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=203770
Collaboration with Schering A G:
http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=202343
Comment: Options will supply about $10 mill. on 1 Dec. 2004-See below. Perhaps another deal will be made as well. I believe that no further capital raising is needed for quite some time, possibly 2 years or more.
2. Capital: Shares: 66.2 mill.
Options: 20.1 mill to pay 50 cents on 1 Dec. 2004 (PBTAK)
200,000 to pay 50 cents on 20/3/2004 (PBTAM)
410,000 to pay 50 cents on 30/6/2005 (PBTAO)
200, 000 to pay 50 cents on 1/10/2005 (PBTAQ)
3. Listings: Australia: "PBT " and Nasdaq: "PRAN" Every Nasdaq share or ADR has 10 PBT shares Quotation: http://quotes.nasdaq.com/quote.dll?mode=stock&kind=&symbol=NVGN&symbol=LOOK&symbol=PRAN&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&FormType=&mkttype=&pathname=&page=quick&selected=PRAN
Currency conversion: http://www.xe.com/ucc/
4. Board: Experience and the Scientific Advisory Board:
http://www.pranabio.com/company_profile/
Research Facilities: University of Melbourne: http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=202080
Massachusetts General Hospital: http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=180416
The Mental Health Research Institute of Victoria; Melbourne Australia
The Harvard Medical School.
5. Business: "The mission of Prana Biotechnology is to develop therapeutic drugs to treat the central disease pathways that cause degeneration of the brain and the eye as we age". Alzheimer's and Parkinson'd diseases are just two of the diseases PBT is interested in but at the moment research centres on Alzheimers:
http://www.pranabio.com/research/research_program.asp
Gerry
Please do your own research and you decide if and when to buy, hold or sell.
- Forums
- ASX - By Stock
- ATH
- ++ data and comment ++
++ data and comment ++
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.19M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $27.94K | 6.050M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 58163299 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 57489001 | 48 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 58163299 | 0.004 |
75 | 84508146 | 0.003 |
19 | 29345125 | 0.002 |
16 | 81865102 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 57455001 | 47 |
0.006 | 17905330 | 28 |
0.007 | 9788861 | 19 |
0.008 | 8393109 | 16 |
0.009 | 4646078 | 9 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 20524121 | ||
Last updated 15.46pm 28/03/2024 ? |
Featured News
ATH (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online